BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34928727)

  • 1. Can one-step nucleic acid amplification assay predict four or more positive axillary lymph node involvement in breast cancer patients: a single-centre retrospective study.
    Kenny R; Wong G; Gould L; Odofin O; Bowyer R; Sotheran W
    Ann R Coll Surg Engl; 2022 Mar; 104(3):216-220. PubMed ID: 34928727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
    Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
    Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.
    Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT
    Breast Cancer Res Treat; 2013 May; 139(1):87-93. PubMed ID: 23576079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
    Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
    Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
    Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
    Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
    Shimazu K; Sato N; Ogiya A; Sota Y; Yotsumoto D; Ishikawa T; Nakamura S; Kinoshita T; Tsuda H; Ohi Y; Akiyama F; Noguchi S
    Ann Surg Oncol; 2018 Sep; 25(9):2603-2611. PubMed ID: 29978372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study.
    Vieites B; López-García MÁ; Martín-Salvago MD; Ramirez-Tortosa CL; Rezola R; Sancho M; López-Vilaró L; Villardell F; Burgués O; Fernández-Rodriguez B; Alfaro L; Peg V
    Clin Transl Oncol; 2021 Jul; 23(7):1377-1385. PubMed ID: 33517542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative Molecular Analysis of Total Tumor Load in Sentinel Lymph Node: A Predictor of Axillary Status in Early Breast Cancer.
    Laohawiriyakamol S; Mahattanobon S; Puttawibul P
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):349-354. PubMed ID: 35092404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Tumor Load of mRNA Cytokeratin 19 in the Sentinel Lymph Node as a Predictive Value of Axillary Lymphadenectomy in Patients with Neoadjuvant Breast Cancer.
    Peña KB; Kepa A; Cochs A; Riu F; Parada D; Gumà J
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
    Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
    Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of total tumour load of sentinel lymph node on survival in early breast cancer patients.
    Peg V; Sansano I; Vieites B; Bernet L; Cano R; Córdoba A; Sancho M; Martín MD; Vilardell F; Cazorla A; Espinosa-Bravo M; Pérez-García JM; Cortés J; Rubio IT; Ramón Y Cajal S
    Breast; 2017 Jun; 33():8-13. PubMed ID: 28254641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of onestep nucleic acid amplification (OSNA) and tumour related factors in the treatment of axillary breast cancer: A predictive model.
    Banerjee SM; Williams NR; Davidson TI; El Sheikh S; Tran-Dang M; Davison S; Ghosh D; Keshtgar MR
    Eur J Surg Oncol; 2016 May; 42(5):641-9. PubMed ID: 26979647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-step nucleic acid amplification assay for intraoperative prediction of advanced axillary lymph node metastases in breast cancer patients with sentinel lymph node metastasis.
    Kubota M; Komoike Y; Hamada M; Shinzaki W; Azumi T; Hashimoto Y; Imoto S; Takeyama Y; Okuno K
    Mol Clin Oncol; 2016 Feb; 4(2):173-178. PubMed ID: 26893855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
    Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
    Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay.
    Bernet-Vegué L; Cantero-González C; Sancho de Salas M; Parada D; Perin T; Quintero-Niño Z; Vieites Pérez-Quintela B; Sánchez-Guzmán D; Castelvetere M; Hardisson Hernaez D; Martín-Salvago MD
    Clin Transl Oncol; 2024 May; 26(5):1220-1228. PubMed ID: 38070048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer.
    Ohi Y; Umekita Y; Sagara Y; Rai Y; Yotsumoto D; Matsukata A; Baba S; Tamada S; Matsuyama Y; Ando M; Sagara Y; Sasaki M; Tsuchimochi S; Tanimoto A; Sagara Y
    Br J Cancer; 2012 Oct; 107(8):1239-43. PubMed ID: 22929881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients.
    Rubio IT; Espinosa-Bravo M; Rodrigo M; Amparo Viguri Diaz M; Hardisson D; Sagasta A; Dueñas B; Peg V
    Breast Cancer Res Treat; 2014 Sep; 147(2):371-80. PubMed ID: 25164972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer.
    Shigematsu H; Ozaki S; Yasui D; Zaitsu J; Taniyama D; Saitou A; Kuraoka K; Yamashiro H; Taniyama K
    Breast Cancer; 2018 Mar; 25(2):191-197. PubMed ID: 29094254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay.
    Fung V; Kohlhardt S; Vergani P; Zardin GJ; Williams NR
    Mol Clin Oncol; 2017 Nov; 7(5):755-762. PubMed ID: 29142748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.